Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Chemotherapy regimen is highly active, well tolerated in advanced cases
May 19th, 2005
Combining weekly vinorelbine (VNB) with a weekly 24-hour infusion of high-dose 5-fluorouracil (5-FU) and leucovorin (LV) was found highly active in women with advanced breast cancer (ABC). Researchers also report that the regimen was well tolerated. For this prospective study, "vinorelbine 25 mg/m2 30-minute intravenous infusion, and high-dose 5-FU 2600 mg/m2 plus LV 300 mg/m2 24-hour intravenous infusion (HDFL regimen) were given on days 1 and 8 every 3 weeks." K.H. Yeh and colleagues, National Taiwan University Hospital, reported, "Between June 1999 and April 2003, 40 patients with histologically...
Source: Women's Health Weekly (2005-05-19)
|
